Where is MDxHealth headquartered?

MDxHealth is located in Irvine, CA.

Who invested in MDxHealth?

MDxHealth has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for MDxHealth?

MDxHealth closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

mdxhealth.com

MDxHealth

MDxHealthk is a molecular diagnostics company that researches and develops epigenetic prostate cancer tests.

Business Model:

Revenue: $22.2M

Employees: 51-200

Geographic Data

Address: 15279 Alton Parkway

City: Irvine

State: CA

Zip: 92618

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$35M

Raised Total:

$92M

Social

Facebook

Twitter

Crunchbase

Metrics

8,180,813Website Global Rank

358Website Monthly Traffic

Twitter Followers

Description

MDxHealthk is a molecular diagnostics company that researches and develops epigenetic prostate cancer tests.

Contact Phone:
+19498126979

Contact Email:

IPO Details

MDxHealth went public on 11/4/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/4/2021

IPO Valuation:
$2B

Ticker Symbol:
MDXH

IPO Price:
$12/share

Amount Raised:
$45M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
6/2020	Debt		$2M	U.S. Small Business Administration.
3/2018	Private Placement		$44.2M
9/2019	Debt		$9.8M	Kreos Capital
12/2018	Grant	1	$80.9k	EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs
11/2016	Equity		$22.6M
12/2008	Post-IPO Equity	1	-	Idinvest Partners Idinvest Partners Idinvest Partners Idinvest Partners
9/2019	Post-IPO Equity		$9.8M
8/2022	Post-IPO Debt		$0	Innovatus Capital Partners Innovatus Capital Partners
6/2013	Post-IPO Equity		$0	Biovest International Petercam Valiance Asset Management Biovest International Petercam Valiance Asset Management
4/2020	Post-IPO Equity		$0	MVM Life Science Partners MVM Life Science Partners MVM Life Science Partners MVM Life Science Partners
11/2021	IPO		$58M
9/2019	Post-IPO Debt	1	$9.8M	Kreos Capital Kreos Capital Kreos Capital Kreos Capital
8/2022	Post-IPO Debt	1	$35M	Innovatus Capital Partners Innovatus Capital Partners
4/2020	Post-IPO Equity	1	$14M	MVM Life Science Partners MVM Life Science Partners MVM Life Science Partners MVM Life Science Partners
9/2019	Post-IPO Debt	1	$9.8M	Kreos Capital Kreos Capital Kreos Capital Kreos Capital
9/2019	Post-IPO Equity		$9.8M
12/2018	Grant	1	$80.9k	EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs
6/2013	Post-IPO Equity	3	$23.6M	Biovest International Petercam Valiance Asset Management Biovest International Petercam Valiance Asset Management
12/2008	Post-IPO Equity	1	-	Idinvest Partners Idinvest Partners Idinvest Partners Idinvest Partners

Acquisitions

Announced Date	Name	Price
8/2022	Exact Sciences - Oncotype DX GPS Prostate Cancer Business
9/2015	Noviogendix Holding

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details